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ABSTRACT  
   
Vitamin C plays an important role in fatty acid metabolism because it is required 
for carnitine synthesis. Vitamin C has been shown to have an inverse relationship with 
weight and body fat percent in a number of studies. However, there has been limited 
research exploring the relationship between vitamin C status and fat oxidation. This 
cross-sectional study investigates the relationship between plasma vitamin C and fat 
oxidation in 69 participants and between plasma vitamin C and body fatness in 82 
participants. Participants were measured for substrate utilization via indirect calorimetry 
while at rest and measured for body fatness via DEXA scan.  Participants provided a 
single fasting blood draw for analysis of plasma vitamin C. Results did not show a 
significant association between vitamin C and fat oxidation while at rest, therefore the 
data do not support the hypothesis that vitamin C status affects fat oxidation in a resting 
state.  However, a significant inverse association was found between vitamin C and both 
total body fat percent and visceral fat.  
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Introduction 
 
     The prevalence of overweight and obesity has risen at an alarming rate over the past 
couple of decades in the United States (1).  Consequently, the incidence of weight-related 
health complications such as heart disease, diabetes, and cancer has risen as well (1,2), 
leading to a dramatic increase in healthcare costs.  In fact, the average annual healthcare 
cost of an obese individual in the United States is over $1000 higher than that of a 
normal weight individual (1).  Considering the urgency of this problem, it is clear that 
further research is essential in order to better understand the physiological mechanisms 
responsible for weight loss and healthy weight maintenance.  
     Research has repeatedly shown an inverse relationship between vitamin C and both 
weight and body fatness (2-4).  In fact, there are multiple hypotheses attempting to 
explain this relationship.  One hypothesis argues that levels of vitamin C are decreased in 
response to the state of oxidative stress that is caused by excess weight (2).  Another 
theory maintains that low levels of vitamin C cause a decrease in carnitine production, 
thereby slowing the rate of β-oxidation, otherwise known as fat oxidation (4).  Vitamin C 
serves as a cofactor that maintains the necessary enzyme activity for carnitine synthesis.  
Carnitine is essential to the process of fat β-oxidation, acting as a shuttle that moves 
long-chain fatty acids from the cell cytosol into the mitochondria to be metabolized (5).   
Several studies have shown that in a state of vitamin C depletion, there is a decrease in 
carnitine production (6,7).  
     Very few studies have been conducted exploring the relationship between vitamin C 
and fat oxidation, and each of those studies experienced limitations.  A randomized 
controlled trial by Johnston and colleagues showed a decreased rate of fat oxidation in 
control participants concomitant with low concentrations of plasma vitamin C, yet 
sample sizes were low (n=3 and 5 for the control and vitamin C groups, respectively) (8).  
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Another study by Ji and colleagues found a similar correlation between vitamin C and fat 
oxidation results.  However, the study was conducted among black sea bream rather than 
in humans, therefore the results are not generalizable to humans (9). 
     There is a need for research that is aimed at further exploring the relationship 
between vitamin C, fat oxidation and body fatness in humans utilizing a large sample 
size.  Efficient fat oxidation is necessary for weight loss and the maintenance of a healthy 
weight and body composition (10,11).  Increased dietary intake or supplementation of 
vitamin C could prove to be a safe, easy and affordable way to help maintain an efficient 
rate of fat oxidation, potentially improving the success of weight loss attempts.  
 
Study Purpose   
     The objective of this study was to examine the relationships between plasma vitamin 
C concentration, fat oxidation and body fatness in healthy adults.  The study utilized a 
convenience sample of omnivorous, vegetarian and vegan adults aged 18-50 years who 
were participating in an investigation examining substrate utilization in adults adhering 
to meatless diets.  The differences between diet groups will not be taken into account for 
the purposes of this study.  The first hypothesis was that there would be a significant 
relationship between vitamin C and fat oxidation.  The second hypothesis was that there 
would be a significant inverse relationship between vitamin C and body fatness.  These 
hypotheses were made based on the results found in prior studies (2-4,8,9). 
 
Definitions 
     There are two terms that may require further definition.  A cofactor is a substance that 
aids in biochemical transformations by participating in enzymatic reactions.  Fat 
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oxidation is the metabolism of fat in the cell mitochondria for the production of 
adenosine triphosphate (ATP), which is a molecule used for energy. 
 
Delimitations   
     Participants were healthy men and premenopausal women aged 18-50 years.  
Qualifying participants had a BMI <30, no history of chronic disease, were free from 
prescription medications with the exception of oral contraception, were not endurance-
trained athletes and women were not pregnant.   
 
Limitations 
     The study had several major limitations.  Muscle carnitine was not measured, 
therefore a correlation could not be made between vitamin C levels and carnitine 
production.  Participants were recruited from a small campus community, as well as 
vegan and vegetarian social networking websites.  Therefore, the study results can only 
be generalized to these specific populations and not to the general public.  Obese 
individuals were excluded from the trial; hence, the relationship between vitamin C 
status and body fatness were examined only in normal weight and overweight 
individuals.  Lastly, the study design was cross-sectional, therefore the results cannot 
prove causation.  A randomized controlled trial should be conducted in the future to 
improve internal validity and to more clearly illustrate a causal relationship. 
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Review of Literature 
 
Overview   
     Overweight and obesity have become a major topic of concern in the biomedical and 
healthcare fields.  Adding to this concern is the inability of scientists and medical 
professionals to come to a consensus as to what is the safest and most effective way to 
lose weight and keep it off.  Further complicating the obesity problem is the fact that 
there is a genetic component that causes increased susceptibility to weight gain and 
retention (12,13).  Thus, further research is essential in order to understand the major 
components that cause weight gain and to determine the major causes of the struggle of 
losing weight once it has been gained.  The physiological roles of vitamin C, the 
physiological role of fat oxidation, the assessment of fat distribution, the relationship 
between vitamin C and weight, and potential benefits of vitamin C supplementation in 
weight loss will be discussed in this paper.  However, the relationships between vitamin 
C and fat oxidation and vitamin C and body fatness will be the focal points. 
 
Vitamin C Overview 
     Physiological roles.  Vitamin C, also known as ascorbic acid or ascorbate, is a 
water-soluble vitamin and an important cofactor in a number of physiological processes.  
It is required for the synthesis of collagen, carnitine, tyrosine, and the neurotransmitters 
norepinephrine and serotonin.  It is necessary for a number of immune reactions and 
also functions as an important antioxidant in the blood and cells (5).  For the purposes of 
this study, the role of vitamin C as a cofactor in carnitine biosynthesis as it relates to the 
role of carnitine in fat oxidation will be discussed further.   
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     Absorption and transport.  Vitamin C in the ascorbate form does not require 
digestion and is readily absorbed across the brush border in each section of the small 
intestine.  Absorption is facilitated by SVCT1 and SVCT2, which are both sodium-
dependent transporters.  These transporters are also present in most organs and tissues, 
sometimes separately, and are therefore thought to be a major mode of absorption for 
vitamin C throughout the body.  In addition to active transport, simple diffusion also 
occurs in the stomach and small intestine when a large amount of vitamin C is ingested.  
Ascorbate in its oxidized form is called dehydroascorbate, which is absorbed into the 
intestinal cells by the glucose transporters GLUT1 and GLUT2 (14).  Once absorbed, 
dehydroascorbate is immediately reduced back to the ascorbate form by the enzyme 
dehydroascorbate reductase.  Reduced glutathione (GSH) is required to reduce the 
dehydroascorbate, and in the process the glutathione is converted to its oxidized state 
(GSSG).  The semidehydroascorbic acid radical is a free radical that is formed during the 
oxidation of ascorbate.  This free radical has a short half-life and does not react well with 
oxygen, therefore it does not typically generate damaging reactive oxygen species.  
Typically, the semidehydroascorbic acid radical is either oxidized to dehydroascorbate, 
or forms ascorbate upon reacting with another ascorbate free radical (15).   
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             Figure 1.  Reduction of Dehydroascorbate to Ascorbate (16) 
 
 
     Sources.  The most common dietary sources of vitamin C include fruits and 
vegetables such as cantaloupe, bell peppers, oranges, lemons, kale, strawberries, 
broccoli, and citrus juices (5).  It is important to note that a number of factors can cause 
a decrease in the vitamin C content of foods, including an increased shelf life, increased 
transport time, storing fruits and vegetables after cutting or juicing, and boiling fruits or 
vegetables (17,18).  Because of this, it is recommended that fruits and vegetables and 
their juices are consumed fresh and with minimal cooking in order to avoid vitamin C 
losses (19).   
     In addition to dietary sources, vitamin supplements are considered a safe and effective 
source of vitamin C, especially if dietary intake is inadequate.  However, when 
consuming vitamin C from supplements, it is important to consider that the 
bioavailability of vitamin C decreases as the dose increases.  Therefore, a high dose of 
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vitamin C will not be as readily absorbed as it would from a lower dose supplement.  In 
fact, the bioavailability of vitamin C from a supplement is 80% for a 100 mg dose, 72% 
for 200 mg, 63% for 500 mg, and as low as 16% for a 12 g dose (20).   
     Dietary Recommendations.  The vast majority of plants and animals are able to 
synthesize vitamin C.  However, a few mammals are unable to synthesize this vitamin, 
including humans, apes, guinea pigs, and fruit bats.  This is due to a genetic mutation in 
the coding of the enzyme gulonolactone oxidase that is required to catalyze the final 
reaction in the process of vitamin C synthesis (21).  Thus, vitamin C is an essential 
nutrient for these mammals and must be consumed regularly through diet or 
supplementation.   
     The current Recommended Dietary Allowances for vitamin C are based on a number 
of factors, including dietary availability, bioavailability, urinary excretion, beneficial 
effects, and prevention of deficiency (22).  It is important to note that pregnant and 
lactating women have an increased need for vitamin C in order to provide adequate 
nutrition to both mother and child (23).  Additionally, smokers have an increased need 
for vitamin C; it is recommended that smokers consume an additional 35 mg/d of 
vitamin C above the RDA for nonsmoking adults in order to decrease the oxidative stress 
caused by cigarette smoke (24).  In fact, a recent study by Dey and colleagues found that 
vitamin C prevented the proliferation of lung cells that had been exposed to cigarette 
smoke, while the smoke-exposed cells that were not treated with vitamin C continued to 
proliferate.  These findings support the importance of vitamin C supplementation for 
smokers (25).   
     Even for non-smokers, vitamin C is depleted relatively quickly.  In fact, it would only 
take one month to develop scurvy if vitamin C intake was discontinued completely (19).  
Table 1 shows the RDA for vitamin C across various groups and age ranges. 
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Table 1. 2010 Dietary Recommendations for Vitamin C (23) 
Age/Group RDA (mg/d) 
Birth - 6 months 40 
7 - 12 months 50 
1-3 years 15 
4-8 years 25 
9-13 years 45 
14-18 years (male) 75 
14-18 years (female) 65 
Adults 19+ (male) 90 
Adults 19+ (female) 75 
Pregnant teens (14-18 y) 80 
Pregnant women (19+) 85 
Lactating teens (14-18 y) 115 
Lactating women (19+) 120 
Smoking males 125 
Smoking females 110 
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     The Tolerable Upper Intake Level (UL) has been set at 2000 mg/day for adults due to 
the possibility of diarrhea and abdominal discomfort when vitamin C is consumed at 
higher levels.  There are no known serious or life-threatening side effects associated with 
consuming more than 2 g of vitamin C per day (23). 
     Deficiency.  A dietary deficiency of vitamin C (plasma concentration < 11 µmol/L) 
can result in scurvy, which is a disease that causes fatigue, pain in the joints, irritability, 
large bruise-colored spots on the limbs, and swollen and bleeding gums.  If left 
untreated, scurvy can result in tooth loss, joint and bone pain leading to decreased 
mobility, and even death (26,27).  Vitamin C deficiency is still quite prevalent in the 
United States.  In the 2003-2004 National Health and Nutrition Examination Survey 
(NHANES), data was collected from 7277 Americans.  It was found that about 13% of 
Americans in the study were vitamin C deficient, with a higher prevalence among low-
income individuals and young adults (28).  While a marginal vitamin C status (plasma 
concentration 11-28 µmol/L) will not typically induce the severe physical symptoms of 
scurvy, it is associated with impaired immune function and fatigue, and could potentially 
cause a decrease in carnitine and collagen synthesis (29).        
 
Fat Oxidation Overview 
     Role in metabolism.  The process of fatty acid oxidation occurs in the cell 
mitochondria of most body tissues.  While short- and medium-chain fatty acids are able 
to diffuse directly through the mitochondrial membrane, long-chain fatty acids must be 
transported through the inner mitochondrial membrane via the carnitine shuttle.  
Outside the mitochondria, the activated fatty acid, also known as fatty acyl CoA, is 
covalently joined to carnitine by the enzyme carnitine acyltransferase I (CAT I).  The 
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shuttle passes the inner mitochondrial membrane and the fatty acid is released into the 
mitochondrial matrix by the enzyme carnitine acyltransferase II (ACAT II) (30).  
     Once the fatty acid is in the matrix, beta oxidation can occur.  Initially, a double bond 
is formed between the α- and β-carbons by the enzyme acyl CoA dehydrogenase.  A 
molecule of water is added by acyl CoA and the β-hydroxy group is oxidized, converting 
the fatty acyl CoA into β-ketoacyl CoA.  The β-ketoacyl CoA is then cleaved at the β-
carbon, which results in a saturated fatty acyl CoA that is two carbons shorter than the 
original fatty acid.  Each of these reactions is then repeated, resulting in two carbons 
being cleaved from the chain each time.  One acetyl CoA is produced each time the 
sequence is repeated, therefore an 18-carbon fatty acid would produce 9 acetyl CoA.  
Each acetyl CoA then goes on to produce 12 ATP in the TCA cycle.  Additionally, each 
cleavage of a carbon-carbon bond that occurs produces 5 ATPs by the oxidation of 
FADH2 and NADH in the electron transport chain (30).  
 
 
Figure 2.  Process of Fatty Acid Oxidation (31) 
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     Measurement.  Fat oxidation is required to metabolize long-chain fatty acids for use 
as energy.  The amount or proportion of fat that is oxidized can be determined by 
measuring an individual’s respiratory exchange values.  This method can also be used to 
determine the extent of utilization of carbohydrate and protein as fuel.  In research 
settings, this is typically done via indirect calorimetry using a metabolic cart.  In order to 
determine respiratory quotient (RQ), the metabolic cart measures the consumption of 
oxygen (O2) and the elimination of carbon dioxide (CO2).  The RQ is determined by 
dividing the amount of CO2 eliminated by the amount of O2 consumed.  It is a measure 
of the types of substrates that are being metabolized for energy production.  An RQ of 1.0 
indicates carbohydrate metabolism, 0.82 indicates protein metabolism, and 0.71 
indicates fat metabolism (32).   
     Metabolic carts have been repeatedly validated as an accurate means of the 
measurement of substrate utilization.  In a study by Phang and colleagues of two popular 
metabolic cart models, it was found that there was ≤2.4% error in CO2 measurements, 
and ≤3.2% error in O2 measurements (33).  Additionally, a study by Blond and 
colleagues showed that two different popular metabolic cart models produced highly 
reliable measurements, with coefficients of variation for repeatability at 1.2% for both 
machines (34). 
     Collecting a participant’s Urinary Urea Nitrogen (UUN) and calculating the 
nonprotein RQ provides more accurate data regarding the types and amounts of 
substrates that are being oxidized.  This value can be calculated by using an individual’s 
UUN output to calculate the amounts of CO2 produced and O2 consumed by the 
metabolism of protein.  This is because 1 gram of nitrogen equates to approximately 4.8 
liters of CO2 expired and 6.0 liters of oxygen consumed.   Subtracting the calculated 
protein values from the CO2/O2 ratio will produce the nonprotein RQ.  The amount of 
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oxidized fat and carbohydrate in grams per liter and by percentage can then be 
determined using the nonprotein RQ table (35). 
     In order to obtain data utilizing a metabolic cart, the participant is fitted with a mask 
connected to two tubes.  Both tubes are connected to the metabolic cart; one tube is for 
inspired O2 and the other is to measure the CO2 that is expired by the participant.  
Before beginning data collection, the participant is allowed to rest in a darkened room, 
allowing them to achieve a resting metabolic state.  After a period of rest, data collection 
begins; O2 consumption and CO2 elimination are measured.  The RQ is then calculated 
from those values as previously discussed (35).  
     Association with weight and body composition.  Fat oxidation has been shown 
in human and animal models to have an inverse relationship with weight and body 
fatness (10,11).  In fact, in a study of Pima Indians by Zurlo et al, lower fat oxidation was 
significantly correlated with weight gain (11).  This finding suggests that when fat is 
oxidized efficiently, it can lead to the maintenance of a healthier body weight (10).  
Conversely, when fat oxidation is inefficient, the body will begin using protein as an 
energy source, which contributes to muscle wasting and a higher percent body fat (36).   
          An illustration of the effect of impaired fat oxidation can be observed in individuals 
with an inborn error of metabolism called primary carnitine deficiency.  Individuals with 
this condition have a mutation in the SLC22A5 gene, causing a defect in the OCTN2 
carnitine transporter.  Thus, depending on the particular mutation, individuals with 
primary carnitine deficiency either have a decreased ability or an inability to shuttle 
long-chain fatty acids into the cell mitochondria for fat oxidation.  Individuals with this 
condition often present with symptoms such as cardiac and skeletal myopathy and 
hepatic steatosis due to an accumulation of long-chain fatty acids in these tissues, 
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hypoketotic hypoglycemia, and a general feeling of fatigue due to the inability to properly 
metabolize long-chain fatty acids (36,37).   
 
Defining Obesity 
     Fat types and distribution.  There are two distinct types of fat in the human body, 
known as brown adipose tissue and white adipose tissue.  Brown adipose tissue is unique 
to mammals.  Its function is to metabolize the macronutrients from food into energy for 
the production of heat.  Additionally, children have a significantly higher proportion of 
brown adipose tissue than adults, which lends itself to the increased metabolic activity of 
childhood.  Due to its role in energy expenditure, the presence of brown adipose tissue is 
protective against obesity and does not increase the risk for chronic disease (38).  The 
composition of brown adipocytes is also quite different than that of white adipocytes; 
brown adipocytes are smaller, contain less fat and more water, and are rich in 
mitochondria and vasculature.  On the contrary, the sole purpose of white adipose tissue 
is fat storage.  White adipose tissue becomes more prevalent with age and is not 
metabolically active.  Therefore, the accumulation of excess white adipose tissue is 
associated with an increased risk for chronic disease (39). 
     The risk associated with body fat is not only based on the amount present, but on the 
location of the accumulated fat.  A number of research studies have shown a significant 
correlation between abdominal fat and chronic diseases such as heart disease and type II 
diabetes (40,41).  In a study by Canoy and colleagues, the data from 24,508 men and 
women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk 
Cohort was examined.  A significant correlation was found between waist-to-hip ratio 
and subsequent cardiovascular events that occurred throughout the cohort study (40).   
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     In recent years, it has been found that visceral fat is a stronger predictor of chronic 
disease risk than abdominal fat alone.  Visceral fat accumulates in the intra-abdominal 
cavity surrounding the internal organs.  It is thought that the accumulation of visceral fat 
occurs due to a dysfunction in adipose tissue storage.  Further, some researchers 
hypothesize that the adipocyte dysfunction that is present in visceral adiposity is 
involved in the pathogenesis of type 2 diabetes (42).  In a prospective cohort study of 520 
Japanese Americans by Bokyo and colleagues, it was found that visceral fat was a 
significant predictor of the development of type 2 diabetes.  This effect was independent 
of other risk factors such as glycemia, insulin secretion, fasting insulin, total and regional 
adiposity, and family history (43). 
     On the contrary, overall body fat is not typically considered a serious risk factor for 
chronic disease without the presence of significant abdominal adiposity (44).  However, 
in a study by Meisinger and colleagues examining data from the Monitoring Trends and 
Determinants on Cardiovascular Diseases (MONICA) Augsburg survey, both abdominal 
and overall body fat were found to be significantly related to subsequent development of 
type II diabetes (41).   
     Assessment.  Body fat percent is often measured for the purposes of determining 
risk for chronic disease.  The American Council on Exercise classifies males as obese 
when they have ≥25% body fat, and females as obese when they have ≥32% body fat.  
Although BMI is commonly used to determine health and disease risk, research has 
shown that body fat percent is a better indicator for disease risk than BMI (45,46).  In 
fact, in a recent study by Goonsageran and colleagues, it was found that BMI falsely 
classified a significant number of both male and female participants as overweight or 
obese although they had healthy levels of body fat (45). 
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     Body fat percent can be measured using a number of techniques, with varying levels of 
accuracy.  The gold standard method of body fat measurement is computed tomography 
(CT).  However, CT is quite expensive, and is therefore impractical for most research 
studies (46).  The most common methods used for research purposes are dual-energy X-
ray absorptiometry (DEXA), bioelectrical impedance, and anthropometric skinfold 
measurements.  All of these are valid and reliable methods for measuring total body fat 
percent (46,47).   
     Waist circumference measurement is another commonly used method of defining 
overweight and assessing risk for chronic disease.  Specifically, waist circumference 
measurement is used to determine abdominal obesity.  In fact, in a study by Abbasi and 
colleagues, greater than normal waist circumferences were positively correlated with 
markers for chronic disease risk such as blood pressure, blood glucose, and triglycerides 
(48).  The waist circumference cut points for increased relative risk are >88 cm (>35 in.) 
in women, and >102 cm (>40 in.) in men (49). 
     Currently, the most valid and reliable methods of measuring visceral fat are DEXA 
and CT (46,47).  Because visceral fat is located in the intra-abdominal cavity, it cannot be 
accurately assessed superficially.  Therefore, it must be measured using imaging 
technologies.  The DEXA scan is the most recent method of assessing body fat, as it was 
initially developed exclusively for the measurement of bone density.  The DEXA scan has 
repeatedly been shown to be a precise and reliable method of measuring body 
composition (50). 
  
Vitamin C and Weight  
     Research overview.  Vitamin C has been shown repeatedly to have an inverse 
relationship with both body weight and body fatness.  In the European Prospective 
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Investigation into Cancer and Nutrition Norfolk (EPIC-Norfolk) cohort study, a very 
large-scale study of 19,068 adult participants, a significant inverse relationship between 
vitamin C and abdominal obesity was observed.  After controlling for a number of 
factors, such as BMI, age, cigarette smoking, and supplement use, the data remained 
significant (40).  Similarly, in a study by Singh et. al., a significant inverse relationship 
was observed between body fat percent and plasma vitamin C concentration in a cross-
sectional study of Indian men (51).  Because these are not experimental studies, they do 
not show causation for the observed effects.  However, the significant relationships 
found between vitamin C status and body fat in these large-scale studies indicate that 
vitamin C may play a role in weight and the accumulation of body fat.  
     There is not enough evidence at this point to determine whether vitamin C deficiency 
could be an underlying cause of overweight and obesity, or a consequence of these 
conditions.  However, many researchers maintain that the energy-dense and often 
nutrient-poor “Westernized” diet is causing widespread micronutrient deficiencies in our 
society (52).  The micronutrient deficiencies resulting from the consumption of this type 
of diet could cause a number of metabolic changes in the body, possibly resulting in an 
increase in weight gain and retention.  In fact, recent evidence has emerged that 
indicates that a reduction in energy intake alone is not as effective for weight loss when 
micronutrient intake is not sufficient (2,3).  This data suggests that micronutrients such 
as vitamin C could be key factors in achieving and maintaining a healthy weight.  There 
are a number of hypotheses attempting to explain the relationship between vitamin C 
deficiency and overweight and obesity.  In fact, it is likely that there are a number of 
physiological factors involved.   The associations between vitamin C and various 
physiological mechanisms involved in weight gain and the accumulation of body fat will 
be discussed briefly. 
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     One theory attempting to explain the inverse association between vitamin C and 
weight maintains that inadequate vitamin C could cause changes in leptin levels, causing 
weight gain and increased inflammation.  Leptin is a hormone that regulates energy 
intake by acting as an appetite suppressant.  Adequate plasma vitamin C has been 
associated with increased leptin sensitivity (2,3).  If sufficient plasma vitamin C is able to 
counteract the effect of leptin resistance, a deficient level of vitamin C could promote a 
state of leptin resistance, which would increase adiposity and the risk of overweight and 
obesity.  When an individual is sensitive to leptin, they are able to receive normal cues 
telling them that they are full, and plasma leptin levels remain low.  Overweight and 
obese individuals tend to have impaired leptin sensitivity, requiring much higher plasma 
concentrations of leptin in order to receive cues of satiety.  This causes them to eat more, 
resulting in increased weight gain (53).  In a cross-sectional study by Garcia and 
colleagues, the researchers hypothesized that there would be a link between plasma 
leptin concentrations, plasma vitamin C, and weight.  They made this hypothesis based 
on the fact that there is a very high prevalence of obesity among Mexican women and 
also a high rate of micronutrient deficiencies, with vitamin C being the highest of these at 
50%.  Nearly 600 Mexican women were tested for plasma levels of glucose, leptin, zinc, 
and antioxidant vitamins A, C, and E.  Additionally, anthropometric measures were 
taken to determine BMI and waist circumference.  The researchers found that vitamin C 
had a significant inverse relationship with BMI, waist circumference, and plasma leptin 
concentrations among obese Mexican women (3).  The relationships found in this study 
support the hypothesis that the plasma vitamin C could play a role in leptin sensitivity, 
thereby impacting weight and body fatness.  
     Another theory focuses specifically on the role of vitamin C as an antioxidant, 
maintaining that a deficiency of dietary antioxidant vitamins results in a state of 
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oxidative stress, causing an increase in the deposition of adipose tissue, particularly in 
the abdominal area.  However, there is debate as to whether deficiencies of antioxidant 
vitamins such as vitamin C are the cause or the result of the condition of obesity.  Some 
researchers hypothesize that the condition of obesity results in a state of inflammation in 
the body, causing rapidly depleted levels of antioxidant vitamins such as vitamin C.  
Regardless of the direction of causality, the low antioxidant status of many overweight 
and obese individuals is associated with a state of oxidative stress in the body.  Oxidative 
stress is associated with increased risk for the development of chronic diseases such as 
heart disease, cancer, and type 2 diabetes that so often plague those with excess fat mass.  
Research has repeatedly shown that obese individuals have lower plasma concentrations 
of antioxidant vitamins such as vitamin C, vitamin E, and beta carotene, indicating that 
this theory merits further investigation to determine the physiological mechanism 
responsible for this relationship (2).   
     There has also been research examining the affect of vitamin C on plasma adiponectin 
levels as a potential mechanism of weight regulation.  Adiponectin is a hormone that 
stimulates increased energy expenditure and helps to prevent insulin resistance.  Plasma 
levels of adiponectin are typically decreased in a state of inflammation.  In a randomized 
controlled trial by Johnston et. al., twenty sedentary obese subjects were randomly 
assigned to receive either a control or a vitamin C supplement.  All subjects consumed a 
low-calorie, high-carbohydrate diet.  After controlling for weight, there was no 
association between vitamin C and adiponectin as a result of the intervention.  However, 
a statistically significant inverse relationship was shown between vitamin C status and 
BMI, waist circumference, and percent body fat after controlling for age and supplement 
use (4).  This data indicates that while there was an inverse relationship between plasma 
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vitamin C and BMI, this effect was not due to a relationship between vitamin C 
concentration and adiponectin levels.   
     Supplementation and weight loss.  There have been few randomized controlled 
trials in humans attempting to induce weight loss with the supplementation of vitamin C, 
although there was an animal study that yielded compelling results.  In a randomized 
controlled trial by Campion et. al., overweight male Wistar rats were randomized to three 
different groups, one of which was fed a vitamin C supplemented diet.  After 56 days on 
the supplemented diet, weight was significantly reduced in the Vitamin C supplemented 
group as compared to the other two groups regardless of caloric intake.  The 
investigators attributed this effect to the antioxidant action of ascorbic acid, maintaining 
that it was able to alter the expression of genes affecting adiposity.  Regardless of the 
physiological mechanism responsible for the observed effect, this study was able to show 
causality due to its experimental study design (54).   
     There are additional weight-related benefits of Vitamin C that exhibit its potential 
advantages for successful weight loss and weight maintenance.  In a randomized 
controlled trial by Huck and colleagues, subjects were randomized to receive either a 
placebo or a 500 mg vitamin C supplement each day for four weeks while on a low-
calorie, low vitamin C diet.  While there was no significant difference in the amount of 
weight lost between groups, the subjects in the vitamin C group experienced a significant 
decrease in both heart rate and perception of fatigue while exercising than those in the 
control group.  Due to the decrease in heart rate and perceived fatigue, the subjects were 
able to perform 10% more work after supplementation with vitamin C.  The researchers 
attributed these findings to the fact that in a state of vitamin C deficiency there is little 
carnitine in the muscles, which causes fatigue.  Additionally, vitamin C is essential for 
the synthesis of norepinephrine, which is a neurotransmitter that affects mood, heart 
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rate, and overall exercise performance.  It is likely a combination of each of these 
components that contributed to the effects witnessed in the study (55).  The data indicate 
that vitamin C supplementation could prove effective in other areas of weight loss and 
weight maintenance.  These findings are important because obese individuals are often 
much more easily fatigued than normal weight individuals, which can prove detrimental 
to weight-loss efforts.  The decreased perceived effort experienced during exercise in 
combination with the increased efficiency that were noted with vitamin C 
supplementation could serve to encourage obese and overweight individuals to stay on 
their exercise regimen, thus enabling them to continue to lose weight successfully.  This 
effect in combination with a potential increase in fat oxidation could work to maximize 
weight loss and exercise adherence in those who typically struggle to lose weight.    
     Another important effect that vitamin C could have in overweight individuals is its 
antioxidant properties.  The conditions of overweight and obesity tend to induce an 
inflammatory state in the body, often resulting in the onset of chronic disease.  The 
antioxidant properties of vitamin C can help to lessen inflammation, which could in turn 
help to prevent or reduce the severity of such life-threatening chronic diseases as cancer, 
heart disease, and type II diabetes.  Of course, as with everything relating to health, there 
is a genetic component that will determine the extent to which each individual will 
respond to a given dietary intervention (11).  Considering each of these factors, it is clear 
that regular supplementation with vitamin C could potentially have a myriad of positive 
effects on overweight and obese patients even beyond weight loss and weight 
maintenance. 
 
 
 
  21 
Vitamin C and Fat Oxidation   
     The role of carnitine.  There is emerging evidence that the inverse relationship 
between vitamin C and weight could be attributed to the role that vitamin C plays in the 
synthesis of carnitine.  Vitamin C serves as the reducing agent in two reactions that 
convert iron from the ferric to ferrous state, which are essential reactions in the 
biosynthesis of carnitine (5).  In fact, muscle tissue exhibits a very high uptake of dietary 
vitamin C.  This effect is likely attributed to the function of vitamin C as a cofactor in the 
synthesis of carnitine and collagen (56).  Carnitine is a molecule that is required for the 
transport of long-chain fatty acids into cell mitochondria for the process of β-oxidation, 
or fat oxidation, the process by which long-chain fatty acids are metabolized for energy.  
In the absence of carnitine, long-chain fatty acids are unable to be transported from the 
cell cytosol into the mitochondria via the ‘carnitine shuttle’.  Carnitine is essential to the 
oxidation of long-chain fatty acids, and vitamin C is necessary for the synthesis of 
carnitine (5).  Based on this premise, the vitamin C status of an individual should be 
directly related to fat oxidation.   
     The relationship between vitamin C and carnitine was further illustrated in a study by 
Johnston and colleagues in a depletion-repletion study of guinea pigs.  Thirty-six male 
guinea pigs were depleted of vitamin C for a period of three weeks to the point that signs 
of scurvy were apparent.  The guinea pigs were then fed a diet containing progressively 
stronger concentrations of vitamin C at 0.5 mg/100 g body weight, 2.0 mg/100 g body 
weight, with each of these repletion periods lasting for four weeks.  Five guinea pigs were 
sacrificed at the end of each period for tissue analysis.  At this time, the remaining guinea 
pigs were divided into groups and supplemented with either 6.0 mg/100 g body weight 
or 10.0 mg/100 g body weight for a final four-week period.  At the end of the depletion 
period, acid-soluble carnitine in the muscle was depleted to levels lower than those 
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found in healthy guinea pigs.  Additionally, after repletion with the 2.0, 6.0, and 10.0 mg 
doses of vitamin C, acid-soluble muscle carnitine increased, although not significantly 
(p=0.087) (57).  This study is important because it shows that in a state of vitamin C 
depletion, muscle carnitine decreases as well.  This is likely due to the fact that vitamin C 
is a cofactor in carnitine synthesis. 
     Research overview.  The relationship between vitamin C and fat oxidation has 
recently become the basis for a hypothesis stating that this link could be a component in 
the pathogenesis of overweight and obesity, although very few studies have been 
conducted to test this hypothesis (8,9).  Because of this physiological link, and the 
relationship that has been found between plasma vitamin C concentrations and body 
weight in a number of studies (2,4), this hypothesis merits further investigation.  There 
have been two recent studies examining the relationship between vitamin C and fat 
oxidation that have concluded that there is a significant relationship between the 
measures of plasma vitamin C and fat oxidation (8,9).   
     Johnston and colleagues conducted a trial that supported this hypothesis.  Initially, a 
group of seventy-eight non-smoking male and female participants ages 18-38 y were 
screened only for vitamin C status.  It was found that 40% of the participants in this 
sample were deficient in plasma vitamin C, which is an unusually high prevalence.  Out 
of this group of individuals, fifteen agreed to participate in an exercise study.  The 
participants’ fat oxidation was recorded as they walked on the treadmill for 60 minutes.  
Within this group, it was found that the subjects with adequate vitamin C had 25% 
higher fat oxidation than those with low levels of vitamin C.  Upon completion of this 
trial, a very small group of eight of the subjects agreed to participate in a randomized 
controlled trial.  These subjects were all given a placebo for the first four weeks of the 
trial in order to deplete vitamin C levels.  In addition, they were given a list of foods high 
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in vitamin C that they were instructed to avoid consuming.  At week five vitamin C levels 
were depleted, at which point the control group continued to take the placebo and the 
intervention group began taking 500 mg of vitamin C each day.  In the intervention trial, 
subjects who took the 500 mg vitamin C supplement each day were found to oxidize fat 
at four times the rate of the vitamin C depleted control group (p=0.011).  Additionally, an 
inverse relationship was found between vitamin C status and protein metabolism, 
indicating that the vitamin C depleted group tended to metabolize protein rather than fat 
(8). These results are quite significant, indicating that there is a need for future research 
utilizing a larger sample size in order to better illustrate a causal effect.   
     In a randomized controlled trial conducted by Ji and colleagues with one-year-old 
black sea bream, the fish were divided into 2 groups and fed either a casein-based diet or 
a casein-based diet fortified with 1,100 mg vitamin C for 60 days.  The black sea bream in 
the vitamin C supplemented group showed a significant increase in acid-soluble 
carnitine.  Additionally, those that consumed the diet high in vitamin C were found to 
experience increased fat oxidation.  The findings of this study are especially important 
because they show a causal link between plasma vitamin C, carnitine, and fat oxidation.  
It is interesting to note that this method was tested in farmed fish in an effort to find a 
way to reduce the excess fat that these fish gain due to relative inactivity as compared to 
the wild species.  Because they did find a significant correlation between vitamin C and 
fat metabolism, this could be considered as a relatively inexpensive supplement for 
farmed fish in the future (9).  Although the results of the study supported the hypothesis, 
more studies need to be conducted in humans, as animal studies are not relatable to a 
human population.   
     The results of the existing studies examining the relationship between vitamin C and 
fat oxidation are very compelling, showing a promising link between vitamin C status 
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and fat oxidation.  Further study is needed in this area utilizing large sample sizes of 
human research participants. 
  
     In summary, very few studies have been conducted examining the link between 
vitamin C status and fat oxidation.  Determining the factors involved in increasing fat 
oxidation could result in a decrease in overall body mass, thereby reducing the 
prevalence of overweight and obesity.  The studies that have been conducted in this area 
have been few and limited; therefore, more research is necessary in this area.  There have 
been several studies that have shown a significant inverse relationship between plasma 
vitamin C concentration and weight.  This relationship requires further investigation in 
order to determine causation.   
     Based on the research that has already been conducted, it appears that vitamin C can 
have a significant impact on fat oxidation during moderate exercise, thereby making 
weight loss easier for individuals on an exercise routine.  Additionally, it could decrease 
the perceived effort expended during exercise, making it easier to adhere to an exercise 
plan.  Based on findings from previous research, vitamin C could improve the weight loss 
efforts of overweight and obese individuals, as well as potentially improving their health.  
Vitamin C supplementation could potentially be a safe and affordable way to help 
achieve and maintain a healthier weight. This is not only because of the weight loss that 
could occur based on the increased efficiency of fat oxidation, but also because of the 
positive health effects that could be experienced because of its antioxidant action, 
possibly alleviating some of the damaging oxidative stress that may have been caused by 
the excess weight.  It is clear that further research in this area could help to advance our 
understanding of the pathology of overweight and obesity, allowing us to find the safest 
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and most effective means of treatment for individuals attempting to achieve a healthier 
body weight.   
 
 
Methods 
 
Participants   
     Men and pre-menopausal women aged 18-50 were recruited from a campus 
population and social networking websites via electronic advertisement.  Participants 
(n=84) included lacto-ovo vegetarians (n=27), vegans (n=28) and omnivores (n=29).  All 
data was analyzed Qualifying participants had adhered to their respective diets for a 
minimum of 6 months, were not endurance trained athletes, had a BMI <30, had no 
known chronic diseases, and were free from all prescription medications other than oral 
contraceptives.  All female participants experienced regular menstrual cycles, and had 
not been pregnant within the preceding six months.  All participants provided written 
consent.  This research was approved by the Institutional Review Board at Arizona State 
University prior to the start of the study. (see Appendix A) 
 
Study Design   
     A cross-sectional design was employed in this study.  Participant recruitment took 
place over a period of two months with the use of fliers, e-mail lists, and advertisement 
in online vegan and vegetarian groups.  An online survey was used to determine 
participant inclusion.  Those who met the criteria and chose to participate in the study 
reported to the laboratory for two separate 90-minute visits.  Written consent was 
obtained from all participants prior to beginning the study.  This study was part of a 
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larger study on fat oxidation in vegans and vegetarians; some data was collected for the 
purposes of the larger study that will not be discussed herein.  
 
Study Protocol   
     Visit 1.  Participants signed the informed consent, completed a health history form, 
and completed a physical activity questionnaire.  A multiple pass 24-hour diet recall was 
conducted with each participant.  Anthropometric measurements were obtained, 
including height, waist circumference, and body weight.  Body fat percentage and lean 
body mass were obtained using DEXA.  Prior to DEXA testing, all female participants 
were required to pass a urine pregnancy test.  For the DEXA assessment, participants 
were positioned face up on a flat bed for 7 minutes to allow the DEXA scanner to pass 
over the entire body.  All participants were required to wear metal-free clothing while 
under the DEXA scanner.  Finally, participants were provided with 24-hour urine vessels 
and instructions on completing the urine collection prior to visit 2. 
     Visit 2.  Participants arrived to the laboratory after a 12-hour overnight fast, with the 
completed 24-hour urine collection.  Each participant was allowed to rest in a dark, quiet 
room for a 30-minute period before obtaining resting energy expenditure (REE). The 
stationary metabolic cart was employed to measure O2 consumption and CO2 
production via indirect calorimetry in order to determine respiratory quotient (RQ) 
values for each participant (60).  In order to collect these measurements, the resting 
participant was fitted with a facemask, which was connected to the metabolic cart with 
an inspired air hose and an expired air hose for the duration of the 30-minute period.  
Participants were asked to consume a typical diet and not to engage in moderate to 
intense physical activity during the 24-hour period preceding REE measurement.  Upon 
completion of REE assessment, a venous blood sample was collected from each 
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participant in order to assess plasma vitamin C.  A research nurse collected all samples 
using EDTA-treated vacutainers and immediately centrifuged each sample. 
     The RQ data used in this study are nonprotein RQ values.  These were calculated for 
each participant using the UUN values obtained from the 24-hour urine collection. (see 
Appendix B)  
 
Measurements   
     Height was measured using a mechanical stadiometer.  Waist circumference was 
measured at the umbilicus and recorded in duplicate using a Gulick tape measure with 
constant tension in order to ensure accuracy.  
 
Laboratory Analysis   
     Plasma was extracted from the fasting blood samples, mixed with an equal volume 
10% TCA, centrifuged, and frozen at -80°C until vitamin C analysis.  At the time of 
analysis, all samples were thawed and the 2,4-dinitrophenylhydrazine method was 
employed to determine ascorbic acid concentrations (58). (see Appendix C) 
 
 
Statistical Analysis 
     Statistics were analyzed using IBM SPSS Statistical Software (Version 19, SPSS Inc., 
Chicago, IL).  When necessary, data were log-transformed for normality, and examined 
for outliers and confounders.  Grouped data was reported as mean ± SD, two-way 
ANOVA was used to examine subject characteristics between groups, and a partial 
Pearson’s correlation was used to assess relationships between variables.  Data was 
considered significant at p≤0.05. 
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Results 
     A total of 82 participants completed the study.  However, due to missing RQ values, 
only 69 participants were included in the analysis of RQ, fat oxidation, and carbohydrate 
oxidation data.  For all other data analysis, all 82 participants were included.  Of these 82 
participants, 27 were omnivores (8 men and 19 women), 27 were lacto-ovo vegetarians (6 
men and 21 women), and 28 were vegans (10 men and 18 women).  The overall mean age 
of participants was 31.0±8.5 years, mean body weight was 67.4±10.2 kg, and the mean 
plasma vitamin C concentration was 0.58±0.16 mg/dl.  The overall mean BMI was 
22.9±2.6 kg/m2, mean waist circumference was 80.1±9.9 cm, mean body fat percent was 
27.8±6.4, and the mean visceral fat was 381.8±335.0 cm3.  The overall mean RQ was 
0.81±0.06, mean fat oxidation was 52.3±16.3 g, and mean carbohydrate oxidation was 
32.5±17.7.   
     Assessment of participant characteristics of plasma vitamin C concentration revealed 
that 23 participants had inadequate plasma levels (<0.5 mg/dl).  Inadequate levels of 
plasma vitamin C were found in 59.3% of participants in the omnivore group, 18.5% of 
the lacto-ovo vegetarian group, and 10.7% of the vegan group.  Further, a correlation 
between vitamin C intake (mg/day) and plasma vitamin C (mg/dl) showed a significant 
positive correlation (p=.041, r=.248). 
     Subject characteristics as grouped by diet type and gender are displayed in Table 2.  
Two-way ANOVA analysis was employed, and the post-hoc test used was the least 
significant difference test.  Two-way ANOVA analysis revealed that age, plasma vitamin 
C, BMI, and carbohydrate oxidation were similar in men and women.  However, gender 
was found to affect weight (p<.001), waist circumference (p=.002), visceral fat (p=.001), 
body fat percent (p<.001), RQ (p=.048),  and fat oxidation (p=.028).  No significant 
interaction was found between gender and diet type.    
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Table 2.  Descriptive Measures Grouped by Gender                    
(mean values, standard deviations) 
  
Males (n=24) Females 
(n=58) 
P-value 
(Gender) 
Age  31.5±8.2 30.5±8.8 0.648 
Weight (kg) 73.8±11.1 61.0±9.2 .000* 
Vitamin C (mg/dl) 0.57±0.15 0.60±0.16 0.332 
BMI 23.4±2.3 22.4±2.9 0.153 
Waist 
Circumference (cm) 85.0±7.7 77.9±9.6 0.002* 
Visceral Fat 546.5±430.6 217.0±239.4 0.001* 
Body Fat Percent 22.7±6.3 32.8±6.5 .000* 
RQ** 0.83±0.06 0.80±0.06 0.048* 
Fat Oxidation** 47.3±16.3 57.3±16.3 0.028* 
Carb Oxidation** 36.8±17.6 28.2±17.8 0.083 
                      *p-values <0.05 represent significantly different results of two-way ANOVA 
                 **69 participants were analyzed for measures of fat oxidation: 18 males,  
                     51 females  
 
 
 
 
     A partial correlation was used to determine the relationships between plasma vitamin 
C and various measures of substrate utilization, controlling for group, gender, and BMI.  
Correlations between vitamin C and measures of substrate utilization are displayed in 
Table 3.  No significant correlations were found between vitamin C and RQ, fat oxidation 
or carbohydrate oxidation.   The same correlations were run on participants after 
omitting vegans, and no significant correlations were found.  Additionally, correlations 
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were run separately on male and female participants, and no significant correlations 
were found with either gender group. 
 
 
Table 3.  Correlations between plasma vitamin C and measures of 
substrate utilization 
 
	  	  
Vitamin C 
(mg/dl) RQ 
Fat 
Oxidation 
Carb 
Oxidation 
Vitamin C 
(mg/dl) 
Correlation 1.000 -0.113 -0.139 0.095 
Significance**  .000*  0.364 0.265 0.446 
RQ 
Correlation 0.113 1.000 -0.92 0.99 
Significance**  0.364 .000*  .000* .000* 
Fat Oxidation 
Correlation -0.139 -0.92 1.000 -0.89 
Significance**  0.265 .000* .000*  .000* 
Carb  
Oxidation 
Correlation 0.095 0.99 -0.89 1.000 
Significance**  0.446 .000* .000* .000* 
*p-values ≤0.05 considered statistically significant  
**2-tailed significance 
 
 
 
 
 
     A partial correlation was used to determine the relationships between plasma vitamin 
C and various measures of body composition, controlling for group, gender, and age.  
Correlations between vitamin C and measures of body composition are displayed in 
Table 4.  A significant inverse correlation was found between plasma vitamin C and body 
fat percent:  r=-.248, and p=.027.  There was also a significant inverse relationship 
between plasma vitamin C and visceral fat:  r=-.251, and p=.025.  These data reveal that 
as plasma vitamin C decreases, there is an increase in both visceral fat and percent total 
body fat.  No significant correlations were found between plasma vitamin C and weight, 
BMI, or waist circumference.  All body composition correlations were also run on the 
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participants after omitting vegans, and no significant correlations were found.  
Additionally, correlations were run separately on male and female participants.  The 
significance for plasma vitamin C and visceral fat was r=-.270 and p=0.044 for females, 
and r=-.272 and p=.221 for males .  The significance for total body fat percent was        
r=-.241 and p=0.074 for females, and r=-.300 and p=.174 for males.  
 
 
 
Table 4.  Correlations between plasma vitamin C and measures of body 
composition 
 
  
Vitamin C 
(mg/dl) 
Weight 
(kg) 
BMI 
Waist 
(cm) 
Visceral 
Fat 
Body Fat 
Percent 
Vitamin C 
(mg/dl) 
Correlation 1.000 -0.053 -0.153 -0.115 -0.251 -0.248 
Significance**  .000*  0.643 0.177 0.313 0.025* 0.027* 
Weight 
(kg) 
Correlation -0.053 1.000 0.807 0.818 0.579 0.628 
Significance**  0.643 .000*  .000* .000* .000* .000* 
BMI 
Correlation -0.153 0.807 1.000 0.825 0.609 0.699 
Significance**  0.177 .000* .000*  .000* .000* .000* 
Waist 
(cm) 
Correlation  -0.115 0.818 0.825 1.000 0.692 0.764 
Significance**  0.313 .000* .000* .000* .000* .000* 
Visceral 
Fat 
Correlation  -0.251 0.579 0.609 0.692 1.000 0.647 
Significance**  0.025* .000* .000* .000*  .000* .000* 
Body Fat 
Percent 
Correlation  -0.248 0.628 0.699 0.764 0.647 1.000 
Significance**  0.027* .000* .000* .000* .000* .000* 
*p-values ≤0.05 are considered statistically significant 
**2-tailed significance 
 
 
 
     Figure 3 illustrates the relationship between plasma vitamin C and percent body fat 
for all participants.  Figures 4 and 5 illustrate the relationship between vitamin C and 
visceral fat for all participants. 
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Figure 3.  Simple Scatter Plot Depicting the Trend Between Body Fat Percent and Plasma 
Vitamin C (n=82) 
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Figure 4.  Simple Scatter Plot Depicting the Trend Between Visceral Fat and Plasma 
Vitamin C (n=82) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  	  Plasma	  Vitamin	  C	  (mg/dL)	  
Vi
sc
er
al
	  F
at
	  (c
m
3 )
	  
  34 
 
 
 
Figure 5.  Bar Graph Depicting the Trend Between Visceral Fat and Plasma Vitamin C 
(n=82) 
 
 
 
 
 
 
Discussion 
 
     There have been two previous studies documenting a significant association between 
plasma vitamin C concentration and fat oxidation, attributing the relationship to the role 
of vitamin C as a cofactor in carnitine synthesis (8,9).  However, no significant 
association was found between vitamin C and fat oxidation in this study.  This could be 
attributed to the fact that this study was a correlational trial assessing fat oxidation of 
individuals in a resting state.  In contrast, the only previous study finding a relationship 
between vitamin C and fat oxidation in humans was an intervention trial conducted in 
	  	  	  	  	  0.18	  
0
	  	  	  	  	  	  0.90	  
  35 
individuals during exercise (8).  The dramatic difference in results between these studies 
indicates that vitamin C could play different roles in substrate utilization depending on 
the level of energy expenditure.  There is a need for further intervention trials exploring 
whether there is a significant correlation between vitamin C and fat oxidation during 
vigorous physical activity and at rest, or whether there appears to be a difference in 
substrate utilization depending on the level of physical activity.  Additionally, obesity has 
been associated with decreased fat oxidation in previous research (59).  Therefore, obese 
individuals were excluded from this study.  Further research is required to explore 
whether obesity significantly impacts the relationship between vitamin C and fat 
oxidation. 
     The potential role of vitamin C in carbohydrate metabolism deserves further 
attention.  In a recent study by Castro and colleagues, a significant correlation was found 
between vitamin C and the metabolism of glucose and lactate in the brain.  The cells of 
the brain are full of ascorbic acid transporters SVCT2 and GLUT1 and 3.  Because of this, 
the brain retains a high concentration of vitamin C even in a state of deficiency.  This 
indicates that vitamin C plays an especially important role in the brain.  The study found 
that vitamin C had a high concentration in neuronal cells and astrocytes, and had the 
ability to switch off glucose metabolism in favor of lactate metabolism in order to 
maintain a high antioxidant capacity in the brains (60).  Because vitamin C could 
potentially play such an important role in carbohydrate metabolism in the brain, further 
study is necessary in this area.   
     A number of studies have found a significant inverse relationship between plasma 
vitamin C concentration and body fat percent (4,40,51).  A significant inverse association 
was found between vitamin C and body fat in this research as well, thus supporting the 
research hypothesis and the findings of previous research.  This association could be 
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attributed to an increase in fat oxidation during periods of physical activity among 
individuals with higher plasma concentrations of vitamin C.  Individuals with higher 
plasma vitamin C would be able to synthesize adequate carnitine to facilitate increased 
fat oxidation during physical activity (8). 
     The most unexpected finding in this research was the significant inverse association 
between plasma vitamin C and visceral fat.  This association has not been reported in any 
other research.  Visceral fat has been shown repeatedly to correlate with an increased 
risk of chronic disease (40,41,61).  In a cross-sectional study of 113 adults by Sironi and 
colleagues, there were significant associations between visceral fat and risk factors for 
both heart disease and diabetes.  Visceral fat was significantly associated with reduced 
insulin sensitivity (p=.002), increased blood pressure (p=.04), and hypertriglyceridemia 
(p<.02).  Overall, there was a significantly higher accumulation of visceral fat in 
individuals with impaired glucose tolerance and type 2 diabetes, and in individuals with 
three or more risk factors for the metabolic syndrome (61). Because such strong 
associations have been shown between visceral fat and markers for chronic disease risk, 
the mechanisms for the accumulation of visceral fat should be explored further.   
     It is important to consider gender as a significant factor in the relationship between 
plasma vitamin C and both visceral fat and body fat percent.  The 2-way ANOVA results 
revealed that there were significant differences in visceral fat and body fat percent 
between males and females.  Additionally, there were changes in the strength and 
significance of the correlations between vitamin C, body fat percent, and visceral fat 
when they were run separately for males and females.  In fact, the only correlation that 
remained significant after separating by gender was between plasma vitamin C and 
visceral fat in females.  However, the strength of the correlations between vitamin C and 
both visceral fat and body fat percent were higher for males as compared to females.  
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This is likely due to the much smaller sample size of males (n=24) as compared to 
females (n=58).  If the sample size of males had been larger, the correlations between 
vitamin C and both visceral fat and body fat percent may have been more significant 
among males than females.  
     There is a need for further research exploring the relationship between vitamin C and 
body fat, especially visceral fat. The cause of this relationship remains unclear because 
this study failed to show a significant relationship between vitamin C status and fat 
oxidation in a rested state.  However, previous research has shown a relationship 
between vitamin C and fat oxidation in a physically active state, therefore this 
relationship cannot be disregarded (8,9).  Additionally, the possibility of a difference in 
the physiological role of vitamin C in varying states of physical activity should be 
considered.  This research showed that vitamin C did not have a significant correlation 
with fat oxidation while the participants were at rest. Therefore, the involvement of 
vitamin C in substrate utilization may be dependent on whether an individual is at rest 
or engaging in physical activity.  Further research is needed in order to explain these very 
different results. 
     In conclusion, the inverse association that was found between vitamin C and visceral 
fat in this research should be further explored in order to determine the physiological 
mechanisms involved as well as the direction of causality.  It is unclear whether 
increased visceral fat could contribute to more rapid depletion of vitamin C due to 
increased inflammation, or whether a lower concentration of plasma vitamin C 
contributes to an increase in the accumulation of visceral fat.  Alternately, the inverse 
relationship that has been found between vitamin C and leptin resistance could be a 
mechanism behind the increased deposition of fat among individuals with inadequate 
vitamin C.  Further research is needed exploring a potential link between leptin, vitamin 
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C, and visceral fat.  The potential differences between genders should be considered in all 
future studies due to the significant difference in body composition between males and 
females.  Additionally, further research is required in order to clarify whether the 
metabolic function of vitamin C is dependent on an individual’s level of energy 
expenditure.   
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RQ = CO2 produced ÷ O2 consumed 
 
 
 
RQ for carbohydrate: 
C6H12O6 + 6 O2 è 6 CO2 + 6 H2O 
 
RQ = 6 CO2 ÷ 6 O2 
 
=1.00 
 
 
 
RQ for Fat:  
C16H32O2 + 23 O2 è 16 CO2 + 16 H2O 
 
RQ = 16 CO2 ÷ 23 O2 
 
=0.696 
 
 
 
RQ for Protein: 
C72H112N2O22S + 77 O2 è 63 CO2 
 
RQ = 63 CO2 ÷ 77 O2 
 
=0.818 
 
 
 
 
Determining Nonprotein RQ: 
 
1 g N Metabolized = 6.0 L O2 consumed, and 4.8 L CO2 produced 
Multiply by g N excreted to determine amounts consumed/produced by protein 
catabolism 
 
Total O2 consumed – amount consumed by protein catabolism = Nonprotein O2 
Total CO2 produced – amount produced by protein catabolism = Nonprotein 
CO2 
 
Nonprotein CO2 ÷ Nonprotein O2 = Nonprotein RQ 
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Thermal Equivalents of Oxygen for the Nonprotein RQ, Including 
Percentage Kilocalories and Grams Derived From Carbohydrate and Fat (57) 
 
    
Percentage kcal 
derived from Grams/Liter O2 
RQ 
kcal/liter 
O2 
Carbohydrate Fat Carbohydrate Fat 
0.70 4.686 0.0 100 0.0 0.496 
0.71 4.690 1.1 98.9 0.012 0.491 
0.72 4.702 4.8 95.2 0.051 0.476 
0.73 4.714 8.4 91.6 0.090 0.460 
0.74 4.727 12.0 88.0 0.130 0.444 
0.75 4.739 15.6 84.4 0.170 0.428 
0.76 4.750 19.2 80.8 0.211 0.412 
0.77 4.764 22.8 77.2 0.250 0.396 
0.78 4.776 26.3 73.7 0.290 0.380 
0.79 4.778 29.9 70.1 0.330 0.363 
0.80 4.801 33.4 66.6 0.371 0.347 
0.81 4.813 36.9 63.1 0.413 0.330 
0.82 4.825 40.3 59.7 0.454 0.313 
0.83 4.838 43.8 56.2 0.496 0.297 
0.84 4.850 47.2 52.8 0.537 0.280 
0.85 4.862 50.7 49.3 0.579 0.263 
0.86 4.875 54.1 45.9 0.621 0.247 
0.87 4.887 57.5 42.5 0.663 0.230 
0.88 4.899 60.8 39.2 0.705 0.213 
0.89 4.911 64.2 35.8 0.749 0.195 
0.90 4.924 67.5 32.5 0.791 0.178 
0.91 4.936 70.8 29.2 0.834 0.160 
0.92 4.948 74.1 25.9 0.877 0.143 
0.93 4.961 77.4 22.6 0.921 0.125 
0.94 4.973 80.7 19.3 0.964 0.108 
0.95 4.985 84.0 16.0 1.008 0.090 
0.96 4.998 87.2 12.8 1.052 0.072 
0.97 5.010 90.4 9.60 1.097 0.054 
0.98 5.022 93.6 6.4 1.142 0.036 
0.99 5.035 96.8 3.2 1.186 0.018 
1.00 5.047 100.0 0.0 1.231 0.0 
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PROCEEDURES)AND)CALCULATIONS)FOR)PLASMA)ASCORBIC)ACID)ASSAY
Weigh Add)up)to
TCA dH20
1 5%)TCA* 5"gms 100ml *TCA:"Trichloroacetic"Acid
2 10%)TCA 10"gms 100ml
Measure Slowly)Add) **)ADD)ACID)TO)WATER
dH20 36N)H2SO4 **"(use"0.75ml"65%"H2SO4"per"sample,"
3 9N)H2SO4 300"ml 100"ml calculate"how"much"needed"and"mix"
4 65%)H2SO4)** 35"ml 65"ml larger"volume"if"necessary)
Weigh Weigh Weigh Slowly)add)))
Thiourea CuSO4N5H2O 2,4)dinitrophenylhydrazine 9N)H2SO4
5 DTC)*** 0.4"gms 0.05"gms 3"gms 100"ml
***"Use"only"100µl"per"sample"so"decrease"amount"depending"on"how"many"samples"you"run
Weigh Add)up)to
Ascorbate 5%)TCA
6 Stock)Solution 5"mg 25"ml
Pipette Add)up)to
Stock)Soln 5%)TCA Use""graduated"test"tubes"to"measure
7 Working)Solution 500µl 5"ml
Sample)Processing
Prepare)Standards
Tube)# µl)Work)Soln µl)5%TCA µl)DTC µg AA/0.5ml AA)mg/dl
1 0 500 100 0 0
2 100 400 100 2 0.4
3 200 300 100 4 0.8
4 300 200 100 6 1.2
5 400 100 100 8 1.6
6 500 0 100 10 2
SAMPLE 500 0 100 sample sample
REAGENTS)IN)TUBE *)CONCENTRATION
SOLUTIONS
Separate"in"to"1"ml"aliquots"and"freeze"
at"Q43°"C"
Draw""blood"into"7ml"EDTA"tube."Mix"well"and"ice"immediately."Spin"at"2800rpm"x"10"min."Mix"2.5ml"
plasma"with"2.5mls"cold"10%"TCA"and"vortex""x"10"sec.""Spin"immediately""at"3500g"x"20"minutes"at"0°"
C.""Aliquot"supernatant"into"3"aliquots"~"1.5"ml"each.""Freeze"immediately"at"Q80°"C."
"
Collect"5ml"urine"in"plain"tube.""Add"5ml"10%TCA+0.2gms"Norit"(acZvated"charcoal)/ml"urine."Spin"
immediately""at"3500g"x"20"minutes"at"0°"C.""Aliquot"supernatant"into"3"aliquots"~"2"ml"each.""Freeze"
immediately"at"Q80°"C."
"
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Assay)Procedure
1 Prepare"standards"as"described"above
2 Incubate"tubes"for"3"hrs"at"37°"C.
3 Add"0.75ml"(750µl)"ICE"COLD"65%"H2SO4"to"all"tubes."Vortex"for"a"count"of"5"seconds"
after"each"addition"to"mix.
4 Let"stand"at"room"temperature"for"30"minutes
5 Read"at"520nm"in"spectrophotometer."Use"tube"#1"as"the"blank.
6 Using"Excel,"produce"standard"curve"using"AA"mg/dl"concentration"as"X"axis"and"
absorbance"as"Y"axis."Produce"a"linear"trendline"and"show"equation."Obtain""
AA"concentrations"in"mg/dl"by"solving"for"y=mx+b.
Volume)calculator:
Blood"samples
Standards 6 urine"samples
Number"of"samples"in"duplicate 0
4.5 mls
0.6 mls
*)NOTE)REGARDING)CALCULATION)OF)AA)IN)mg/dl
Factor"of"0.2"used"to"convert"AA"µg/0.5ml"to"mg/dl."This"factor"takes"into"account"that"only"0.5ml"of
sample"is"used"and"then"converts"μg/ml"to"mg/dl
stock"Soln:"0.2mg/ml
Working"Solution:"0.2mg/ml convert"to" convert"to
μg/ml mg/dl
Tube Work)Soln Conc x)2)= x0.1
1 ….
2 0.1"ml 2µg/0.5ml 4μg/ml 0.4mg/dl
3 0.2"ml 4μg/0.5ml 8μg/ml 0.8mg/dl
4 0.3"ml 6μg/0.5ml 12μg/ml 1.2mg/dl
5 0.4"ml 8μg/0.5ml 16μg/ml 1.6mg/dl
6 0.5"ml 10μg/0.5ml 20μg/ml 2.0mg/dl
OR)multiply)Conc)x)0.2)to)convert)μg/0.5ml)to)mg/dl
DTC"required
65%"H2So4"requried
  
